Remove tag fda-innovation-challenge
article thumbnail

Allurion: first HealthTech IPO of 2023 via SPAC with Compute Health

Lloyd Price

Allurion's gastric balloon is FDA-approved and has been shown to be effective in helping people lose weight. Here are some of the key takeaways from Allurion's IPO: The company's gastric balloon is a non-surgical weight loss device that is FDA-approved. Additionally, the company has been criticized for its high price tag.

article thumbnail

The most-read tech and aging blog posts from 2019

Aging in Place Technology Watch

In July, Tim Cook apparently did not want to get into the world of FDA regulation. In this new watch, both the ECG feature and fall detection have received FDA clearance within 30 days of applying, startling some observers who noted that closer to 150 days was more typical for a medical device. Don't laugh, though.

article thumbnail

Technologies for Older Adults from CES 2022

Aging in Place Technology Watch

AARP Innovation Labs , CTA Foundation accessibility awards , and numerous other in-person, remote, and hybrid sub-events went on (sort of) as scheduled. Eargo 6, its sixth-generation FDA Class II exempt hearing aid and most powerful device yet, was launched at CES 2022. All text is from public media. All are worth a look. . Learn more.